AQP9 and metabolic dysfunction-associated steatotic liver disease: All women used for this study were in a premenopausal state and females during pregnancy or lactation period were excluded, suggesting that the hepatic suppression of AQP9 by estrogens seen in female rats during short-term fasting (31) may not apply to humans, at least in morbid obese women with NAFLD.